Darzalex Faspro Market Report 2026

Darzalex Faspro Market Overview

• The Darzalex Faspro market growth in the historic period has been driven by clinical success of daratumumab, limitations of intravenous infusions • Market expansion is supported by increasing multiple myeloma diagnosis rates, expansion of outpatient oncology care • Growth Driver: Darzalex Faspro Market Growth Fueled by Rising Cancer Incidences • Market Trend: Advancements In Darzalex Faspro For Multiple Myeloma Treatment And Regulatory Approvals • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Darzalex Faspro Market?

Darzalex faspro is a medication used to treat multiple myeloma, a type of blood cancer, and works by targeting and depleting CD38-positive cells to enhance the immune system's ability to fight cancer, administered as a subcutaneous injection for quicker delivery compared to traditional intravenous infusion. The main indications of darzalex faspro are multiple myeloma and AL amyloidosis. Multiple myeloma is a cancer that originates in plasma cells, which are found in bone marrow. It disrupts normal blood cell production, leading to bone damage and complications in other organs. Darzalex faspro is used as an effective treatment for managing multiple myeloma and enhancing patient outcomes. It is administered orally, parenterally, and through other means and distributed through various channels such as hospitals, pharmacies, retail pharmacies, online pharmacies, and others. The end users include hospitals, specialty clinics, homecare, and others.

What Is The Darzalex Faspro Market Growth Forecast?

The growth in the forecast period can be attributed to increasing multiple myeloma diagnosis rates, expansion of outpatient oncology care, preference for shorter treatment times, ongoing clinical trials, supportive reimbursement frameworks. Major trends in the forecast period include shift toward subcutaneous oncology therapies, growing adoption of cd38 targeted treatments, preference for faster drug administration, expansion of multiple myeloma treatment options, improved patient convenience in oncology care.

What Are The Drivers Of The Darzalex Faspro Market?

The growing incidence of cancer is anticipated to drive the expansion of the darzalex faspro market in the coming years. Cancer refers to a group of diseases characterized by uncontrolled cell growth and spread to other parts of the body. The rise in cancer cases is driven by an aging population, unhealthy lifestyle choices, increasing environmental exposures, better detection methods, and genetic predispositions. Darzalex Faspro helps in cancer cases as it is an effective treatment that targets and depletes CD38-positive cells, enhancing the immune system’s ability to fight cancer, which helps in managing and reducing the progression of multiple myeloma and other related malignancies. For instance, in April 2024, according to the American Cancer Society, a US-based professional organization company, in 2022, there were 20 million new cancer diagnoses and 9.7 million cancer-related deaths globally. By 2050, the number of new cancer cases is expected to rise to 35 million. Therefore, the growing incidence of cancer is expected to bolster the darzalex faspro industry. The global expansion of healthcare infrastructure is poised to drive the growth of the darzalex faspro market in the coming years. Healthcare infrastructure refers to the physical and organizational structures, facilities, resources, and systems that are necessary for delivering healthcare services to a population. The global expansion of healthcare infrastructure is driven by several key factors, including the aging global population, the increase in chronic diseases, and technological advancements. Healthcare infrastructure is crucial for patients receiving darzalex faspro, as it enables access to trained healthcare professionals for administering the subcutaneous injection in outpatient settings, reducing the need for lengthy hospital visits. For instance, in May 2023, according to the American Health Care Association, a US-based nonprofit organization, the United States had 6,129 hospitals, representing a 0.591% increase from the previous year when there were 6,093 hospitals. Therefore, the expansion of healthcare infrastructure is expected to bolster the darzalex faspro industry.

Key Players In The Global Darzalex Faspro Market

Major companies operating in the darzalex faspro market are Johnson & Johnson Services Inc.

Global Darzalex Faspro Market Trends and Insights

Major companies operating in the darzalex faspro market are focusing on advancing regulatory approvals for combination regimens, such as quadruplet therapy, to improve patient outcomes and extend survival. Quadruplet therapy refers to a treatment regimen that involves four distinct therapeutic agents, each targeting different pathways of the disease to achieve a synergistic effect. For instance, in July 2024, Johnson & Johnson Services Inc., a US-based pharmaceutical company, received approval from the US Food and Drug Administration (FDA) for DARZALEX FASPRO (daratumumab and hyaluronidase-fish) in combination with bortezomib, lenalidomide, and dexamethasone (D-VRd) for induction and consolidation treatment in newly diagnosed multiple myeloma patients eligible for autologous stem cell transplantation. This approval supports the adoption of more intensive combination regimens aimed at achieving deeper and more durable responses in patients.

What Defines the Darzalex Faspro Market?

The darzalex faspro market consists of sales of darzalex faspro 1,800 mg. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Darzalex Faspro Market Report 2026?

The darzalex faspro market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the darzalex faspro industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.